• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 7, 2021
Deals

May 7 Quick Takes: SpringWorks makes bet on TEAD portfolio; plus CRISPR-Nkarta, Valneva and more

Read More
BioCentury | May 10, 2019
Emerging Company Profile

HopeMed: Targeting PRLR for chronic diseases

How HopeMed’s anti-PRLR antibody could treat endometriosis, alopecia with fewer side effects
Read More
BioCentury | Apr 19, 2019
Finance

Hope for China’s academic spinouts

How professors are joining China’s drive toward innovative biotech
Read More
BioCentury | Apr 11, 2019
Company News

Hope Medicine in-licenses Bayer’s BAY 1158061

Read More
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

Read More
BioCentury | Jul 25, 2016
Clinical News

XOMA 213: Phase II started

Read More
BioCentury | Aug 21, 2014
Distillery Therapeutics

Indication: Cancer

Read More
Items per page:
1 - 7 of 7